2005
DOI: 10.1016/j.jconrel.2005.09.039
|View full text |Cite
|
Sign up to set email alerts
|

Folate-conjugated methoxy poly(ethylene glycol)/poly(ɛ-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
143
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 236 publications
(145 citation statements)
references
References 35 publications
2
143
0
Order By: Relevance
“…In tumor treatment the micelles system has proven effective in regression of tumor size while minimizing damage to the healthy tissues [4] and is being actively investigated in conjunction with hyperthermia [5], ultrasound [6], specific enzyme-induced cleavable bonds [7][8][9], and specific ligands or antibodies [10][11][12][13] for active targeting purposes.…”
Section: Introductionmentioning
confidence: 99%
“…In tumor treatment the micelles system has proven effective in regression of tumor size while minimizing damage to the healthy tissues [4] and is being actively investigated in conjunction with hyperthermia [5], ultrasound [6], specific enzyme-induced cleavable bonds [7][8][9], and specific ligands or antibodies [10][11][12][13] for active targeting purposes.…”
Section: Introductionmentioning
confidence: 99%
“…This differential expression has lead to the development of folate receptor-mediated diagnostic and therapeutic agents for the treatment of various cancers (Liu et al, 2005;Park et al, 2005). In this study, we have prepared and evaluated folate-conjugated micelles as a potential antitumor drug delivery system.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, folic acid has been used as a targeting ligand to deliver therapeutic agents to cancer cells due to its high binding affinity to folate receptors, low immunogenicity, ease of modification, small size and functional stability (Park et al, 2005). Several folate-drug conjugates have been reported in the literatures, such as folate-low molecular weight drugs , Aronov et al, 2003, Satyam, 2008, folate-liposomes (Gabizon et al, 2004, Shi et al, 2002, Wu et al, 2006, Xiang et al, 2008, folate-gene vectors (Kim et al, 2007, Liang et al, 2008, Yoshida et al, 2006, folate-nanoparticles (Pan andFeng, 2008, Chen et al, 2008), folate-micelles (Park et al, 2005, Alemdaroglu et al, 2008, Kim et al, 2008, Yang et al, 2008, Chu et al, 2009, folate-prodrugs (Henne et al, 2006, Suzuki et al, 2007, Cavallaro et al, 2006, folate-imaging agents (KE et al, 2004.…”
Section: Research Articlementioning
confidence: 99%
“…Therefore, targeting delivery of anticancer drugs has been widely investigated because it would not only improve therapeutic efficiency but also reduce the dose of drug that must be administered to achieve a therapeutic response, thus minimizing negative side effects (PARK et al, 2005). Recently, ligand-mediated targeting of anticancer drugs to tumor cells that express selectively or overexpress receptors has become a promising strategy for improving the therapeutic effect (SAPRA and ALLEN, 2003, MAJUMDAR et al, 2004, QIAN et al, 2002, DE et al, 2008.…”
Section: Introductionmentioning
confidence: 99%